Ocugen furnishes investor presentation; no material new details available from filing

Ocugen, Inc.

Exhibit 99.1 presentation attached to 8-K but full content not provided in the filing excerpt.
Ocugen (OCGN) continues to highlight gene therapy pipeline; no financial or clinical updates disclosed.
Presentation posted on company website for investor use; no specific new events or numbers reported.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.